CPT code 82554 designates laboratory measurement of creatine kinase (CK) isoforms, a targeted isoenzyme analysis used to distinguish specific CK subtypes in a patient specimen. Nationally, CK isoform testing contributes to diagnostic pathways for muscle injury, myocardial damage, and certain neuromuscular disorders where isoenzyme differentiation informs clinical interpretation. The code is most commonly billed for quantitative laboratory services performed in clinical or hospital laboratories.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for CK isoform testing, the typical site and service type, and what to expect in payer coverage and billing practice. The publication summarizes benchmark considerations and coding guidance where available, highlights common modifiers and billing nuances, and outlines implications for laboratory workflow and documentation. Data not available in the input are noted where applicable.